HDAC inhibitors still need a home run, despite recent approval

Nat Rev Drug Discov. 2015 Apr;14(4):225-6. doi: 10.1038/nrd4583.
No abstract available

Publication types

  • News

MeSH terms

  • Drug Approval
  • Epigenesis, Genetic / drug effects
  • Histone Deacetylase Inhibitors / pharmacology
  • Histone Deacetylase Inhibitors / therapeutic use*
  • Histone Deacetylases / genetics
  • Humans
  • Multiple Myeloma / drug therapy
  • United States
  • United States Food and Drug Administration

Substances

  • Histone Deacetylase Inhibitors
  • Histone Deacetylases